Naviscan, a developer of organ-specific molecular imaging, has received CE mark approval for its Positron Emission Mammography (PEM) scanner and PET-guided biopsy accessory.
The scanner uses PET technology to produce tomographic images which aids physicians to visualize breast tumors with an unprecedented resolution of 1.6 mm.
The company has expanded PEM scanner distribution into 13 European countries and has already received its first two orders in Germany and Switzerland.
Naviscan chairman and CEO Paul Mirabella said CE mark approval for Naviscan’s technology is an accomplishment and they are thrilled that women in Europe can now benefit from their 3-D, molecular breast imaging (MBI) system.